ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Mercyhealth Transforms Revenue Cycle Management With Arintra's Autonomous Coding Solution

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Mercyhealth, a leading multi-regional health system serving 55 communities across northern Illinois and southern Wisconsin, has transformed its revenue cycle operations with Arintra’s AI-powered autonomous coding platform. Faced with mounting revenue recognition challenges, Mercyhealth adopted Arintra to boost coding accuracy, improve efficiency, and support its growing patient volume. This collaboration supports Mercyhealth’s commitment to delivering high-quality care while driving financial growth.

Results

By implementing Arintra, Mercyhealth achieved:

  • 5.1% Revenue Uplift: Enhanced coding accuracy directly boosted revenue.
  • 50% Reduction in Work Queue Aging Days: Through instant autonomous coding and faster claim submission.
  • 88% Direct-to-Billing Automation: A streamlined coding process alleviated administrative burden.

Kimberly Scaccia, Mercyhealth’s Vice President of Revenue Cycle, explains the impact: “Before, we were touching about 30% of claims from a coding perspective. Arintra allows us to ensure revenue accuracy based on documentation and be compliant, while freeing up coders to focus on highly complex services and value added initiatives."

The Challenge

Mercyhealth processes over 130,000 claims monthly, creating coder burnout and backlogs. These challenges were compounded by evolving Medicaid policies and compliance mandates. Despite these pressures, the organization remained committed to delivering world-class healthcare and accelerating growth, recently opening a new hospital and planning a cancer institute.

The Arintra Solution

Arintra’s autonomous coding platform, powered by Generative AI, seamlessly integrated with Mercyhealth’s Epic EHR system, ensuring easy deployment and optimized workflows resulting in a seamless experience for coders and significant efficiency gains.

“Arintra provided much more than automation. It delivered clarity, auditability, and the ability to proactively address documentation gaps,” said Kelly Pierson, Mercyhealth’s Director of Coding. “Our team is now free to focus on complex cases and projects that bring greater value.”

Discover More

To learn how Mercyhealth achieved these results, read the full case study here.

About Mercyhealth

Founded in 1883, Mercyhealth is a $5 billion healthcare system with 7 hospitals and 85 care locations, serving over 55 communities across northern Illinois and southern Wisconsin. With more than 7,500 employees, Mercyhealth is committed to delivering evidence-based medicine and exceptional care close to home.

About Arintra

Arintra, a leader in autonomous medical coding, accelerates and optimizes reimbursements for healthcare organizations. Powered by Generative AI, Arintra integrates seamlessly into EHR systems, ensuring smooth adoption with zero workflow disruptions and clear, explainable coding decisions to enhance revenue cycle efficiency. Arintra automates coding— from charge capture to claim submission—all within the EHR.

Our mission is to improve the financial health of hospitals and provider organizations through automation, making healthcare more affordable and accessible.

For more information, visit www.arintra.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.28
-2.28 (-0.91%)
AAPL  273.05
+2.82 (1.04%)
AMD  274.95
-3.44 (-1.24%)
BAC  53.95
+0.04 (0.07%)
GOOG  335.40
-4.00 (-1.18%)
META  670.91
-17.64 (-2.56%)
MSFT  418.07
-4.72 (-1.12%)
NVDA  202.06
+0.38 (0.19%)
ORCL  177.58
+2.52 (1.44%)
TSLA  392.50
-8.12 (-2.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.